SEED Therapeutics
PrivateLast Round
Series A
Extension
Sep 23, 2025
Est. Valuation
$130M
Total Funding Raised
$80M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
SEED Therapeutics is a biotechnology company that develops targeted protein degradation therapeutics using its proprietary RITE3™ molecular glue platform to treat diseases in oncology, neurodegeneration, and immunology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SEED Therapeutics Comparables
Compare SEED Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Degron Therapeutics | 88% | |
| Plexium | 88% | |
| Magnet Biomedicine | 88% | |
SEED Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Sep 23, 2025 | ||||
| Series A | Aug 6, 2024 | ||||
| Series A | Nov 13, 2020 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 20, 2026
Open roles increased to 29, 116% of headcount.
- Aug 14, 2025
Named a finalist for the 2025 Prix Galien USA 'Best Start-Up' Award.
SEED Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about SEED Therapeutics's valuation, stock price, and market status.